FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19970811000001102: Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Mar 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
67280101000001119 Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
67280201000001114 Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Is a Pramipexole 2.62mg modified-release tablets 30 tablet true Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Has AMP Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) true Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Has specific active ingredient Pramipexole dihydrochloride monohydrate false Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Has specific active ingredient Pramipexole dihydrochloride monohydrate true Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Has basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start